Discontinued — last reported Q4 '22

Other

Foreign

Insmed Foreign remained flat by 0.0% to $1.12M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 32.4%, from $845.00K to $1.12M. Over 4 years (FY 2021 to FY 2025), Foreign shows an upward trend with a 29.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementIncome Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityModerate
First reportedQ1 2015
Last reportedQ4 2022

How to read this metric

Higher values indicate higher tax obligations in international markets.

Detailed definition

The portion of the total income tax provision that is payable to foreign governments for the current reporting period. T...

Peer comparison

Standard tax disclosure for multinational corporations.

Metric ID: other_current_foreign_tax_expense_benefit

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$1.59M$1.35M$2.23M$3.38M$4.48M
YoY Change—-15.1%+65.9%+51.5%+32.4%
Range$1.35M – $4.48M
CAGR+29.6%
Avg YoY Growth+33.7%
Median YoY Growth+42.0%
Current Streak3 years growth

Frequently Asked Questions

What is Insmed's foreign?
Insmed (INSM) reported foreign of $1.12M in Q4 2025.
How has Insmed's foreign changed year-over-year?
Insmed's foreign increased by 32.4% year-over-year, from $845.00K to $1.12M.
What is the long-term trend for Insmed's foreign?
Over 4 years (2021 to 2025), Insmed's foreign has grown at a 29.6% compound annual growth rate (CAGR), from $1.59M to $4.48M.
What does foreign mean?
Current income tax expense owed to foreign jurisdictions.